Overview of the microbiota in the gut-liver axis in viral B and C hepatitis

doi:10.3748/wjg.v27.i43.7446

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 27, Issue 43

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5324)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

363

WORD

162

HTML

2689

Figures (1-2)

300

Tables (1-2)

291

Sum=3805

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

316

Download

433

Sum=749

Publishing Process of This Article

Item

Count

Browse

325

Download

445

Sum=770

Nov 21, 2021 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Nov 21, 2021; 27(43): 7446-7461
Published online Nov 21, 2021. doi: 10.3748/wjg.v27.i43.7446

Open in New Tab Full Size Figure Download Figure

Figure 1 The mechanisms by which the gut microbiome influences the immune system. LPS: Lipopolysaccharides; SCFA: Short-chain fatty acids.

Open in New Tab Full Size Figure Download Figure

Figure 2 The gut-liver axis in liver diseases. TGR5: G-protein-coupled bile acid receptor; PAMPs: Pathogen-associated molecular patterns; LPS: Lipopolysaccharides; TLR: Toll-like receptor.

Citation: Neag MA, Mitre AO, Catinean A, Buzoianu AD. Overview of the microbiota in the gut-liver axis in viral B and C hepatitis. World J Gastroenterol 2021; 27(43): 7446-7461
URL: https://www.wjgnet.com/1007-9327/full/v27/i43/7446.htm
DOI: https://dx.doi.org/10.3748/wjg.v27.i43.7446